The Glasgow-based biopharmaceutical company Mironid , has successfully concluded a €39.9 million ($46 million) Series B funding round to advance its primary drug candidate for Autosomal...
BMW’s 5 Series Facelift Includes Updates to the M5 Model BMW’s upcoming facelift for the 5 Series appears to be more extensive than initially thought, with...
Subscribe to our weekly newsletter below and never miss the latest News or an exclusive offer.